Institute of Personalized Medicine (IPM)
Pharmacogenomics aims at understanding how variations in the human genome affect the response to medications.
Our researchers are working to generate new knowledge, and to develop tools and algorithms that can help in personalizing medicine utilizing a patient’s genetic profile and other factors to achieve maximum therapeutic benefit with minimum toxicity.
News
Pharmacogenomics Conference 2020
The third biennial pharmacogenomics conference will take place over two days, June 11-12, 2020. The conference will provide PGx implementation education on a range of topics through lectures and smaller group breakout sessions. Registration opens on January 15, 2020.
Cindy Luo
Pamala Jacobson received the Sara Evans Faculty Woman Scholar/ Leader Award from the University of Minnesota Women’s Center, Office for Equity and Diversity and was honored at their Celebrating Changemakers Awards event on October 11, 2018.
This session highlighted the social and cultural challenges associated with providing care to local Native American tribes in Minnesota, who face larger health disparities than other populations.
David Stenehjem works in the rapidly growing field of outcomes research, which guides his research on midostaurin in FLT3-mutated acute myeloid leukemia.
Weekly Genomics Scan
This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.
Precision Medicine Seminar Series
"Gene-Based Dose Optimization in Children"
Jakob T. Brown, PharmD, MS
Assistant Professor, Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota
Friday, December 6
2 PM - 3 PM, 5-125 Moos Tower
Dr. Jacob Brown’s expertise lies primarily within pediatric pharmacotherapy, pharmacogenetics, pharmacogenomics, and pharmacokinetics. Dr. Brown joined the faculty of the University of Minnesota College of Pharmacy on its Duluth campus in 2014. He is one of the investigators on the University’s Grand Challenge Research Initiative working towards statewide PGx implementation.
This event is free and open to the public. Light refreshments will be served.
Pharmacogenomics
Conference
Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Conference on June 22 was at capacity with over 310 registrants in attendance. Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas. Read about the event here.
University Precision Medicine Initiatives
Precision Medicine and Health Consortium (PMHC)
Bringing together scientists, healthcare providers, patients and payers in the area of precision medicine to promote research, education and the use of precision medicine and health to improve human health.
Minnesota Precision Medicine Collaborative (MPMC)
Transforming health and advancing equity by generating precision treatments of disease to advance health outcomes for all Minnesotans.